The Top Cannabis Stocks in Canada: A Comprehensive Guide

The cannabis industry in Canada has experienced significant growth since the nationwide legalization of marijuana in 2018. With the legalization, the industry has contributed a staggering $43 billion to Canada's GDP and created approximately 150,000 jobs, according to an economic study.

However, despite the impressive growth, the cannabis industry has faced numerous challenges, including regulations and compliance issues that have hindered the growth of marijuana companies. Additionally, the continued existence of the black market for cannabis has presented obstacles for some companies looking to expand their operations1.

In this comprehensive guide, we will delve into the world of cannabis stocks, exploring what they are, the different types of companies involved, and the top cannabis stocks on the Toronto Stock Exchange (TSX). We will also discuss the pros and cons of investing in the cannabis industry and help you determine if these stocks have a place in your investment portfolio.

‍

Understanding Cannabis Stocks

Cannabis stocks refer to companies that are engaged in the cultivation, distribution, and sale of medical and recreational marijuana. These companies can be categorized into three main groups:

• Recreational growers: These are agricultural centers responsible for cultivating and harvesting marijuana for casual use.
• Ancillary businesses: These "non-plant" companies focus on developing advanced agricultural equipment for growers, such as improved lighting systems and more efficient grow centers.
• Biotechnology companies: These healthcare companies utilize marijuana as the base for pharmaceuticals and other medical treatments.

In addition to these three main categories, there are other types of cannabis companies, including those involved in packaging, transportation, retail sales, and consulting services. However, the recreational growers, ancillary businesses, and biotechnology companies make up the majority of the top cannabis stocks in Canada.

Top Cannabis Stocks in Canada

With the legalization of marijuana in 2018, Canada has seen a surge in small-cap cannabis stocks. To help you identify potential long-term winners, we have compiled a list of some of the top cannabis stocks on the Toronto Stock Exchange (TSX)1:

Cannabis Stock

Canopy Growth (TSX:WEED): Canada's largest producer of medical and recreational marijuana.

Aurora Cannabis (TSX:ACB): Major producer of medical marijuana.

OrganiGram Holdings (TSX:OGI): Micro-cap cannabis stock that posted impressive numbers in 2022.

‍

Canopy Growth

Headquartered in Smiths Falls, Ontario, Canopy Growth is one of the largest cannabis companies in Canada. With operations in the United States, Canada, and parts of Europe, the company has established a strong global presence in the emerging cannabis market1.

Canopy Growth produces a wide range of cannabis and cannabinoid products under different brands, including Tweed, Spectrum, CraftGrow, and the vaporizer Storz & Bickel. While the company primarily focuses on recreational marijuana, it also cultivates cannabis for medical purposes and utilizes cannabinoid-related substances in healthcare and beauty products1.

Since its initial public offering (IPO) in 2018, Canopy Growth's stock has experienced significant volatility. After reaching a peak of around $50 per share in 2019, it has since declined to pre-2019 levels due to poor earnings and uncertainty surrounding federal legalization in the United States1.

‍

Aurora Cannabis

Based in Edmonton, Alberta, Aurora Cannabis is a major player in the medical marijuana industry. The company operates in 25 countries and has eight licensed production facilities spread across various regions.

What sets Aurora Cannabis apart from other cannabis stocks is its diverse global presence. In addition to its Canadian operations, the company has expanded into Europe, Latin America, and Australia. It has also ventured into research in genomics and biotechnology, using cannabis as a base for its studies.

While Aurora Cannabis reached large-cap territory in 2019, it has since experienced a significant decline in stock value, falling over 98% from its 2018 value. However, the company's increased presence in Europe, which is a promising market for cannabis stocks, may give investors reason for optimism1.

‍

OrganiGram Holdings

OrganiGram Holdings is a cannabis company that focuses on both recreational and medical marijuana. Although it initially started as a medical marijuana distributor, the company has expanded its product offerings to include cannabis-infused edibles and soft-chew candies1.

While the cannabis industry as a whole has struggled to generate strong net revenues, OrganiGram Holdings reported impressive numbers in 2022. The introduction of new products into the market resulted in a 90% increase in sales and a 26% increase in its top line. Although this has not translated into significant momentum for the stock, it is a positive development for an industry that has been burning through cash.

Pros of Investing in Cannabis Stocks

Investing in cannabis stocks offers several potential advantages for investors:

• Significant growth potential: The cannabis industry still has plenty of room to expand, especially considering that marijuana is not yet legalized in all 50 U.S. states. This untapped market represents a significant growth opportunity for cannabis stocks1.
• New medical applications: While non-medical marijuana currently dominates the cannabis market, ongoing research into the medical applications of marijuana presents promising prospects. Biotech companies are exploring the potential of cannabis in treating conditions such as Alzheimer's disease, cancer, dementia, and Crohn's disease1.

‍

Cons of Investing in Cannabis Stocks

Despite the potential advantages, investing in cannabis stocks carries certain risks:

• Overhyped stocks: The enthusiasm surrounding the cannabis industry has led to some companies being valued above their underlying business fundamentals. Investors should exercise caution and carefully evaluate the financial health and prospects of cannabis stocks.
• Regulatory uncertainty: The legalization of marijuana is still a relatively new development, and governments in North America are still grappling with how to regulate the industry effectively. This ongoing regulatory uncertainty can contribute to short-term volatility in the cannabis market as companies adjust to changing regulations1.
• Market saturation: The cannabis industry is still in its early stages, but it is already crowded with numerous marijuana companies. With so many options available, it can be challenging to identify the companies that will thrive and survive in the long term1.

Is Investing in Cannabis Stocks Right for You?

While there is a compelling argument for including cannabis stocks in an investment portfolio, it is crucial to approach this emerging industry with caution. Many cannabis companies are still in their infancy, and if marijuana sales continue to grow as projected, the value of these stocks could soar.

However, given the industry's youth and the uncertain future it faces, it is recommended to exercise caution and not allocate a significant portion of your portfolio to cannabis stocks. Not only is the industry still evolving, but most cannabis companies are currently burning through cash and are far from profitable1.

As time passes, the cannabis market will likely undergo consolidation, with only companies demonstrating strong business fundamentals and sustainable growth potential surviving. Therefore, it is essential to conduct thorough research and analysis before making any long-term investment decisions in the cannabis industry.

In conclusion, the cannabis industry in Canada has experienced significant growth since its legalization, offering potential investment opportunities. However, investors should be aware of the risks involved and conduct comprehensive research before adding cannabis stocks to their portfolios. The industry's future remains uncertain, and only time will reveal which companies will thrive in this emerging market.

‍